Demonstration of Effective Watchman device in patients with auricular fibrillation

Thanks to a new studio it is possible to use devices to prevent cerebral complications due to sanguine affections.

Dr. Francisco Perez Gil, Electrophysiologist at the San Lucas Episcopal Center.
Dr. Francisco Pérez Gil, Electrophysiologist at the San Lucas Episcopal Center.

Belinda Z. Burgos González
Agencia Latina de Noticias Medicina y Salud Pública

Technological advances in medicine have fundamentally improved the ability to look for alternatives that are effective for those who care about first-rate patients, as well as cardiac patients.

A new study ensures that the Watchman is an effective mechanism for preventing possible cerebral affections, a therapy that can replace the use of warfarin in large amounts of patients with auricular fibrillation without valvular.

El Dr. Francisco Pérez Gil, electrophysiologist at the San Lucas Episcopal Center, who was the first to implant the Watchman device in Puerto Rico, combining the details of a recent study of patients with auricular fibrillation that benefited from this therapeutic treatment. do not respond to traditional therapies for these conditions.

The auricular fibrillation is a cardiac irregularity that characterizes the coronary artery with rapid healing of the cerebrovascular lesions, during which the app is superior to the superior coronary coronary arteries. created in the patient debilitating and agotament, mainly.

The patients who suffer from auricular fibrillation have 5 weeks more risk of presenting a “stroke”. Historically, warfarinas have been used, but we are currently using new anticoagulants to control the risk that patients may experience a cerebrovascular event. Although many of them do not tolerate the new drugs or can not kill them under any other condition, “explained the doctor.

Treatment options

Many pharmacies suelen create secondary effects in the patient that is administered with the same, and because of this, new therapies are required that are effective for the sake of being able to establish security in the individual during his treatment.

“For these patients who do not tolerate the new drugs, there is an option on the Watchman device that is placed in the auricular orifice. The orejuela is like an appendix that sells the auricle and is in this zone where more than 90% of the coagulas produced in the heart are formed, ”the specialist indicated.

Watchman device

And while the Watchmen herramiento is not only effective, it is beneficial for the patient with a cardiac affection, and there is a risk of complications and possible manifestations of new and severely impaired comorbidities.

“If the log is compressed, it means that the risk to patients is diminished and that more than 90% of the coronary heart disease is present. The FDA approved Watchman in 2015, in order to reduce the risk of stroke in patients who do not tolerate anticoagulants, ”said Dr.

Study of the technology of technology

Thanks to the various studies, it can be validated that a device like the mention can be used in the attention of the first line of patients who have auricular fibrillation, as the doctor indicates that it is valid and has complete security that this element is can be used at a generic level and that patients have access to the same.

“The study is staffed with 41 patients and now we have 80 patients in the midst of the descriptions that have been described. The results were satisfactory and were related to FDA approval studies. We have an implantation rate of about 99%, of the 80 patients we have only one that cannot be implanted and is performed by anatomy, ”the doctor indicated.

The Watchman is effective and secure for the Puerto Rican population and has no previous study in this section and is valid in the literature that predominates its attacks on Hispanics, thanks to investigations and has alternative therapies.

Finally, the specialist indicates that at the moment the mayor’s work of cardiologists is promoting the education needed for the Watchman to be seen as the most effective treatment of primary care patients who do not respond to treatment with anticoagulants and arrhythmias.